Development and Validation of the Oxford Skin Cancer Treatment Scale, a Patient-Reported Outcome Measure for Health-Related Quality of Life and Treatment Satisfaction After Skin Cancer Treatment

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Validation study reveals a targeted outcome measure for skin cancer treatment, highlighting the role of patient-reported outcomes in evaluating care.

The Oxford Skin Cancer Treatment Scale provides a dedicated measure to evaluate health-related quality of life and treatment satisfaction after therapies for skin cancer.
Development and validation of this patient-reported outcome measure focus on quantifying postoperative recovery alongside satisfaction with skin cancer treatment modalities.
Application of these patient-reported outcome measures highlights the necessity of standardized metrics to compare therapeutic options across diverse skin cancer treatment plans.

Kantor et al. (2024) studied this question.

View Full Paper

Ask AI

Bookmark

Validation study reveals a targeted outcome measure for skin cancer treatment, highlighting the role of patient-reported outcomes in evaluating care.